The Adherence Cliff: Why Pharma Loses Patients After Year One
Patient support programs have become a cornerstone of modern pharmaceutical commercialization. Many brands invest heavily in helping patients start therapy with welcome kits, nurse...
The Simplicity Advantage: Why the Best Drug Doesn’t Always Win
When pharmaceutical companies compete, most conversations begin with efficacy and safety. Those factors remain essential, but they are no longer the only drivers of...
The Second Prescription: Where Pharma Brands Are Really Won—or Lost
Winning a patient's first prescription often feels like crossing the finish line. In reality, it marks the beginning of a much longer treatment journey....
The Diagnosis Delay Crisis: Why Finding the Disease Isn’t the Same as Finding Treatment
Receiving a diagnosis should mark the beginning of effective care. However, for millions of patients, it is only the start of another difficult journey....
The Navigation Gap: Why Patients Still Get Lost After Diagnosis
Receiving a diagnosis often feels like reaching the finish line. In reality, it is only the first step in a much longer journey. Many...
When Drugs Meet Brain Tech: Pharma’s Next Marketing Frontier
Marketing for brain-computer interfaces is emerging as one of the most important strategic considerations for pharmaceutical companies entering the age of intelligent neurotechnology. As...
Why Most Doctors Don’t Prescribe the “Best” Drug First
Many pharmaceutical launches generate excitement during their first few months. Medical conferences highlight promising clinical data, key opinion leaders share positive experiences,...
The DeSci Revolution: When Medical Research No Longer Starts Inside Pharma
Medical innovation has traditionally followed a familiar path. Universities conduct research, pharmaceutical companies fund development, and healthcare professionals introduce new therapies to patients. However,...
The Capacity Crisis: Why Great Drugs Still Can’t Reach Patients
Launching an innovative therapy is only half the battle. Today, many pharmaceutical companies face a challenge that has little to do with clinical evidence...
Your Biggest Competitor Isn’t Another Drug—It’s Something Else Entirely
For decades, pharmaceutical marketers have focused on outperforming competing brands within the same drug class. However, healthcare has changed dramatically. Today, a medication may...
